Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

NCT01339286 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: atomoxetine

Sponsor

Peking University